Screening for hepatitis b and c viral infections among pregnant women attending the Bolan Medical Complex Hospital and Sandeman Provincial Civil Hospital Quetta, Pakistan.

Authors

  • Zunera Tanveer Bolan Medical College Quetta, Pakistan.
  • Irshad Ahmad Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.
  • Muhammad Shahid Javed Sargodha Medical College, University of Sargodha, Sargodha.
  • Shoaib Ahmad Malik Sargodha Medical College, University of Sargodha, Sargodha.
  • Nargis Haider Kakar Bolan Medical College Quetta, Pakistan.
  • Mushtaq Ahmad Hayatabad Medical Complex, Peshawar, Pakistan.
  • Simon G. Patching School of Biomedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.
  • Muhammad Naeem Lady Reading Hospital Peshawar, Pakistan.
  • Mohammad Zahid Mustafa University of Balochistan, Quetta, Pakistan.

DOI:

https://doi.org/10.29309/TPMJ/2020.27.08.3129

Keywords:

Hepatitis B, Hepatitis C, Infection, Quetta, Screening, Vertical Transmission

Abstract

Infectious diseases caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) are a worldwide burden to health, especially in developing countries. Pakistan has one of the highest levels of HBV and HCV infection, causing a severe health problem with significant challenges and priorities. To prevent vertical transmission of infection, regular screening of pregnant women for HBV and HCV is vital. Objectives: The objective of this study was to evaluate the prevalence of HBV and HCV virus in pregnant women having prenatal care. Study Design: Cross-Sectional study. Setting: Bolan Medical Complex Hospital and Sandeman Provincial Civil Hospital Quetta. Period: August 2017 to July 2018. Material & Methods: Blood serum samples were screened for HBV surface antigen (HBsAg) and for anti-HCV using immunochromatography methods. Results: A total of 12,209 pregnant women were tested over a period of one year (August 2017 to July 2018). The overall HBV infections frequency was 1.3% (95% CI 1.1-1.4%) and for HCV infections it was 0.6% (95% CI 0.6-0.7%). Whilst there was only small month-wise variation in the occurrence of HBV and HCV infections, HBV prevalence was highest in May (1.7%) and HCV prevalence was highest in August and December (0.8%). Conclusions: Screening of all pregnant women for HBV and HCV is essential for reducing and eliminating vertical transmission of infection. Risk factors for infection need to be avoided and managed properly.

Author Biographies

Zunera Tanveer, Bolan Medical College Quetta, Pakistan.

MBBS, M.Phil

Demonstrator Physiology

Irshad Ahmad, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.

DVM, Ph.D

Assistant Professor

Muhammad Shahid Javed, Sargodha Medical College, University of Sargodha, Sargodha.

MBBS, Ph.D

Assistant Professor Physiology

Shoaib Ahmad Malik, Sargodha Medical College, University of Sargodha, Sargodha.

MBBS, MS, Ph.D

Assistant Professor Biochemistry

Nargis Haider Kakar, Bolan Medical College Quetta, Pakistan.

MBBS, M.Phil

Assistant Professor Physiology

Mushtaq Ahmad, Hayatabad Medical Complex, Peshawar, Pakistan.

MBBS, FCPS

Associate Professor Ophthalmology

Simon G. Patching, School of Biomedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

B.Sc (Hons.), Ph.D)

 

Muhammad Naeem, Lady Reading Hospital Peshawar, Pakistan.

MBBS, FCPS

Assistant Professor Ophthalmology

Mohammad Zahid Mustafa, University of Balochistan, Quetta, Pakistan.

DVM, Ph.D

Assistant Professor

Center for Advanced Studies in

Vaccinology and Biotechnology (CASCAB),

Downloads

Published

2020-07-10